233,574 Shares in The Clorox Company (NYSE:CLX) Bought by Raymond James Financial Inc.

Raymond James Financial Inc. purchased a new stake in shares of The Clorox Company (NYSE:CLX - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 233,574 shares of the company's stock, valued at approximately $37,935,000. Raymond James Financial Inc. owned approximately 0.19% of Clorox at the end of the most recent reporting period.

Several other large investors have also recently modified their holdings of the stock. Integral Investment Advisors Inc. increased its stake in Clorox by 4.1% during the 4th quarter. Integral Investment Advisors Inc. now owns 1,718 shares of the company's stock valued at $279,000 after purchasing an additional 67 shares in the last quarter. HCR Wealth Advisors grew its holdings in shares of Clorox by 1.0% during the fourth quarter. HCR Wealth Advisors now owns 6,870 shares of the company's stock valued at $1,116,000 after buying an additional 68 shares during the last quarter. Sound View Wealth Advisors Group LLC increased its position in shares of Clorox by 6.1% during the fourth quarter. Sound View Wealth Advisors Group LLC now owns 1,345 shares of the company's stock valued at $218,000 after acquiring an additional 77 shares in the last quarter. Wedbush Securities Inc. raised its holdings in Clorox by 1.2% in the 4th quarter. Wedbush Securities Inc. now owns 7,624 shares of the company's stock worth $1,238,000 after acquiring an additional 94 shares during the last quarter. Finally, Brooklyn Investment Group lifted its position in Clorox by 163.8% in the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company's stock valued at $25,000 after acquiring an additional 95 shares in the last quarter. Hedge funds and other institutional investors own 78.53% of the company's stock.

Clorox Stock Performance

Clorox stock traded down $0.09 during midday trading on Monday, hitting $139.69. The stock had a trading volume of 82,476 shares, compared to its average volume of 1,299,406. The company has a current ratio of 0.94, a quick ratio of 0.60 and a debt-to-equity ratio of 20.52. The Clorox Company has a 52-week low of $127.60 and a 52-week high of $171.37. The company has a market capitalization of $17.21 billion, a PE ratio of 38.17, a P/E/G ratio of 2.62 and a beta of 0.61. The firm's fifty day moving average is $146.57 and its two-hundred day moving average is $156.36.

Clorox (NYSE:CLX - Get Free Report) last announced its quarterly earnings data on Monday, February 3rd. The company reported $1.55 EPS for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same quarter in the prior year, the business posted $2.16 EPS. On average, research analysts forecast that The Clorox Company will post 7.15 EPS for the current year.

Clorox Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Wednesday, April 23rd will be paid a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a yield of 3.49%. The ex-dividend date is Wednesday, April 23rd. Clorox's dividend payout ratio (DPR) is presently 133.33%.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on CLX. Barclays decreased their price target on Clorox from $139.00 to $134.00 and set an "underweight" rating for the company in a research note on Friday, April 11th. DA Davidson decreased their target price on Clorox from $171.00 to $169.00 and set a "neutral" rating for the company in a research report on Wednesday, February 5th. UBS Group dropped their price target on shares of Clorox from $176.00 to $154.00 and set a "neutral" rating on the stock in a report on Thursday. Citigroup lowered their price objective on shares of Clorox from $165.00 to $150.00 and set a "neutral" rating on the stock in a research report on Monday, April 14th. Finally, JPMorgan Chase & Co. lowered their price target on Clorox from $173.00 to $151.00 and set a "neutral" rating on the stock in a report on Friday, April 11th. Three equities research analysts have rated the stock with a sell rating, ten have given a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat, Clorox has a consensus rating of "Hold" and an average price target of $153.83.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.